Stay updated on TQB2450 Combo vs K Drug in NSCLC Clinical Trial
Sign up to get notified when there's something new on the TQB2450 Combo vs K Drug in NSCLC Clinical Trial page.

Latest updates to the TQB2450 Combo vs K Drug in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe history shows a minor administrative update with Revision: v3.3.4 added and Revision: v3.3.3 removed, with no changes to study data or public-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe record history now shows Revision: v3.3.3 and the footer no longer includes the HHS Vulnerability Disclosure or Revision: v3.3.2. These changes reflect site maintenance and do not affect trial data or core page content; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check45 days agoChange DetectedRecord History shows Revision: v3.3.2 as the latest entry (replacing Revision: v3.3.1).SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision v3.3.1 was added and a previous revision v3.2.0 was removed from the record history, a minor metadata update that does not affect study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the government funding/operating status notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check74 days agoChange DetectedA new version entry dated 2021-08-18 was added to Record History, noting updates to Study Status and Recruitment Status.SummaryDifference0.1%

Stay in the know with updates to TQB2450 Combo vs K Drug in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TQB2450 Combo vs K Drug in NSCLC Clinical Trial page.